{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial Comparing Intracutaneous and Transcutaneous Suturing of Ileostomies"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients were randomised 1:1"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants were aged 18-80 years, scheduled for ileostomy, and provided informed consent."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomised 1:1 to receive either intracutaneous (IC) or transcutaneous (TC) suturing."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to compare the effects of intracutaneous versus transcutaneous suturing of ileostomies on faecal leakage and quality of life."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was faecal leakage within 3 months post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computerised, with allocation concealed in sealed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applied to outcome assessors, patients, or clinicians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between April 2011 and February 2016, 339 patients were randomised: 170 to the IC group and 169 to the TC group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on an intention-to-treat basis."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Leakage rates were higher in the IC group (52.4%) compared to the TC group (41.4%), with a risk difference of 11.0% (95% CI 0.3 to 21.2)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Skin irritation rates were high in both groups (78.2% IC vs 72.2% TC), with no significant difference (risk difference 6.1%, 95% CI -3.2 to 15.1)."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NTR2369."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}